ArticleAdvances in therapy2024

Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study.

Christopher J Patriquin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.